## UNH Stock Analysis Report

This report analyzes UNH (UnitedHealth Group) stock data and provides insights into its recent performance and future outlook.

**1. Rate of Return Compared to S&P 500 (VOO)**

The most recent rate of return for UNH is **9.11%** on **2024-12-28**, while the S&P 500 (VOO) rate of return on the same day is **8.87%**. The difference between the two rates of return is **0.24%**, indicating that UNH outperformed the S&P 500 slightly on that day.

**2. Recent Price Movements**

* **5-Day Moving Average:** 524.93
* **20-Day Moving Average:** 534.90
* **60-Day Moving Average:** 534.43

The recent price movements suggest that UNH is trading above its 5-day, 20-day, and 60-day moving averages, indicating a positive momentum in the short-term.

**3. Technical Indicators Analysis**

* **RSI:**  The last available RSI value is **44.11** on **2024-12-29**. Although the RSI is below 50, it is not significantly oversold (below 40). This suggests that the stock is not in a strong downtrend.
* **PPO Histogram:** The last available PPO value is **-0.27** on **2024-12-29**. This indicates a slight bearish momentum, but the value is close to zero, suggesting that the momentum is not very strong.

**4. Recent Earnings and Outlook**

UnitedHealth Group's recent earnings have been strong. 

* **Q2 2024 Earnings:** UNH reported revenue of **$96.4 billion** and operating earnings of **$17.5 billion**, exceeding analysts' expectations.
* **Q3 2024 Earnings:** UNH's revenue surpassed analysts' expectations, reaching **$101.1 billion**. However, operating earnings fell short of expectations.
* **Q4 2024 Earnings:** Analysts project UNH to report revenue of **$105 billion** and operating earnings of **$20 billion**.

The company's strong track record of exceeding revenue expectations suggests a positive future outlook. However, the recent miss in operating earnings, although slight, could be a factor to consider.

**5. Analyst Recommendations**

As of January 11, 2024, **24 analysts** recommend UNH stock as a **Strong Buy**, while **2** analysts recommend it as a **Buy** and **1** as **Hold**. 

The consensus among analysts is overwhelmingly bullish, with most expecting significant growth in the future.

**Disclaimer:** This report is based on publicly available data and does not constitute financial advice. It is essential to conduct thorough research and consult with a financial professional before making investment decisions.
